MAM
Martingale Asset Management Portfolio holdings
AUM
$4.08B
1-Year Return
20.69%
This Quarter Return
-5.21%
1 Year Return
+20.69%
3 Year Return
+65.38%
5 Year Return
+128.32%
10 Year Return
+323.81%
AUM
$5.02B
AUM Growth
-$481M
(-8.7%)
Cap. Flow
-$132M
Cap. Flow
% of AUM
-2.64%
Top 10 Holdings %
Top 10 Hldgs %
12.65%
Holding
930
New
93
Increased
368
Reduced
299
Closed
113
Top Buys
| 1 |
CVS Health
CVS
|
$26M |
| 2 |
Zions Bancorporation
ZION
|
$21.8M |
| 3 |
Huntington Ingalls Industries
HII
|
$20.8M |
| 4 |
Exxon Mobil
XOM
|
$17.8M |
| 5 |
Hartford Financial Services
HIG
|
$14.3M |
Top Sells
| 1 |
Prologis
PLD
|
$22.9M |
| 2 |
Public Service Enterprise Group
PEG
|
$15.8M |
| 3 |
ANSS
Ansys
ANSS
|
$15.5M |
| 4 |
Copart
CPRT
|
$14.4M |
| 5 |
Y
Alleghany Corporation
Y
|
$13.2M |
Sector Composition
| 1 | Healthcare | 21.18% |
| 2 | Technology | 18.59% |
| 3 | Consumer Staples | 12.7% |
| 4 | Financials | 12.23% |
| 5 | Industrials | 11.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
INDT
726
DELISTED
INDUS Realty Trust, Inc. (MD) Common Stock
INDT
| $274K | 0.01% |
5,213
| – | – |
|
727
Sierra Bancorp
BSRR
$412M
| $269K | 0.01% |
13,607
+2,600
| +24% | +$51.4K |
|
728
Recursion Pharmaceuticals
RXRX
$2.01B
| $269K | 0.01% |
25,200
+14,100
| +127% | +$151K |
|
729
ConocoPhillips
COP
$116B
| $268K | 0.01% |
2,617
+191
| +8% | +$19.6K |
|
|
PCSB
730
DELISTED
PCSB Financial Corporation
PCSB
| $268K | 0.01% |
14,909
| – | – |
|
731
Horizon Bancorp
HBNC
$853M
| $267K | 0.01% |
14,859
+3,201
| +27% | +$57.5K |
|
732
Steel Dynamics
STLD
$19.8B
| $267K | 0.01% |
+3,753
| New | +$267K |
|
733
eGain
EGAN
$178M
| $266K | 0.01% |
35,965
+5,412
| +18% | +$40K |
|
734
Ecolab
ECL
$77.6B
| $264K | 0.01% |
1,822
-15,460
| -89% | -$2.24M |
|
735
Guaranty Bancshares
GNTY
$562M
| $264K | 0.01% |
7,585
+197
| +3% | +$6.86K |
|
736
InnovAge Holding
INNV
$512M
| $264K | 0.01% |
44,866
+31,700
| +241% | +$187K |
|
737
Allogene Therapeutics
ALLO
$255M
| $262K | 0.01% |
24,231
-800
| -3% | -$8.65K |
|
738
Haemonetics
HAE
$2.62B
| $261K | 0.01% |
+3,523
| New | +$261K |
|
739
F5
FFIV
$18.1B
| $260K | 0.01% |
1,791
| – | – |
|
740
Exact Sciences
EXAS
$10.2B
| $254K | 0.01% |
+7,800
| New | +$254K |
|
741
PMV Pharmaceuticals
PMVP
$77.4M
| $254K | 0.01% |
21,276
+1,494
| +8% | +$17.8K |
|
742
Marathon Petroleum
MPC
$54.8B
| $251K | 0.01% |
+2,524
| New | +$251K |
|
743
Edgewise Therapeutics
EWTX
$1.64B
| $249K | 0.01% |
+25,215
| New | +$249K |
|
744
Gentherm
THRM
$1.1B
| $249K | 0.01% |
5,002
-400
| -7% | -$19.9K |
|
745
Ooma
OOMA
$346M
| $248K | ﹤0.01% |
20,112
+600
| +3% | +$7.4K |
|
746
Tarsus Pharmaceuticals
TARS
$2.43B
| $246K | ﹤0.01% |
14,329
-20
| -0.1% | -$343 |
|
747
10x Genomics
TXG
$1.74B
| $246K | ﹤0.01% |
+8,604
| New | +$246K |
|
748
Safe Bulkers
SB
$455M
| $245K | ﹤0.01% |
99,082
| – | – |
|
749
Red River Bancshares
RRBI
$431M
| $243K | ﹤0.01% |
4,906
-400
| -8% | -$19.8K |
|
750
iRadimed
IRMD
$916M
| $239K | ﹤0.01% |
7,934
+5
| +0.1% | +$151 |
|